Bioventus Inc (BVS) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 63/100

gurufocus.com · 2026-10-13

On October 12, 2026, Bioventus Inc (BVS) shares rose 3.6% today, currently priced at $13.53. This move comes amid a 52-week range of $6.46 to $15.89.GF Valueâ„¢

TickrTrends take: Bioventus Inc operates in the Healthcare sector where valuation metrics warrant careful monitoring. While the stock recently gained 3 percent in price movement, TickrTrends' assessment of fair valuation contrasts with the GF Value indicator's overvalued signal, suggesting investors should track whether the company's fundamentals can support current pricing levels. A GF Score of 63 indicates moderate quality, which makes the divergence between fair value and overvalued assessments a key point for shareholders to evaluate as new financial data emerges.

Read the full story at gurufocus.com →